INBRX-109 - Business-News-Today.com

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

Genesis Minerals (ASX: GMD) launches A$5.6bn Vault bid as Regis faces five-day test

Read More

Pharma Industry News

Inhibrx Biosciences’ Ozekibart sets new benchmark in rare bone cancer treatment and advances toward 2026 BLA filing

Find out how Inhibrx Biosciences’ Ozekibart delivered breakthrough results in chondrosarcoma and is advancing toward a 2026 BLA filing—read more now!

bySoujanya Ravi

October 24, 2025

web analytics